A Multicentered Randomized Study on Early versus Rescue Calsurf Administration for the Treatment of Respiratory Distress Syndrome in Preterm Infants

Abstract

Objective Surfactant and noninvasive ventilation are two major strategies for the treatment of neonates with respiratory distress syndrome (RDS). However, the optimal time for surfactant administering is yet controversial. This study compared the early and rescue Calsurf administration in preterm infants with RDS.

Study Design Preterm infants born between 26^0/7 and 32^6/7 weeks of gestation and needed nasal continuous positive airway pressure (nCPAP) immediately after birth were randomly assigned to the early or rescue Calsurf treatment group. In the early treatment group, neonates were intubated, administered surfactant with bag–mask ventilation, and extubated to nCPAP (INSURE [intubation–surfactant–extubation]). In the rescue treatment group, InSurE was given until the clinical manifestation and chest X-ray displayed RDS. The primary outcome was to compare the reintubation rate within 72 hour age between the two groups.

Results Among 305 neonates randomized to the early (n = 154) and rescue (n = 151) groups, the reintubation rate within 72 hours of age in these two groups did not differ significantly (p > 0.05). The incidence of oxygen dependence until 36 weeks' corrected age was similar in both groups.

Conclusion No differences were observed between early and rescue Calsurf treatment groups with respect to the reintubation rate within 72 hours of age and the incidence of bronchopulmonary dysplasia.

Keywords

continuous positive airway pressure - neonatal respiratory distress syndrome - bronchopulmonary dysplasia - surfactant

Note

All the authors contributed equally to the study.

• References

• 1 Rojas MA, Lozano JM, Rojas MX. , et al; Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009; 123 (01) 137-142
• 2 Dargaville PA, Aiyappan A, De Paoli AG. , et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology 2013; 104 (01) 8-14
• 3 Chang LW. Collaborative Study Group for Bronchopulmonary Dysplasia of Prematurity in China. Incidence and risk factors of bronchopulmonary dysplasia in prematureinfants in 10 hospitals in China [in Chinese]. Zhonghua Er Ke Za Zhi 2011; 49 (09) 655-662
• 4 Rong ZH, Li WB, Liu W. , et al. Nasal bi-level positive airway pressure (BiPAP) versus nasal continuous positive airway pressure (CPAP) in preterm infants ≤32 weeks: a retrospective cohort study. J Paediatr Child Health 2016; 52: 493-498
• 5 Eibisberger M, Resch E, Resch B. Surfactant replacement therapy in extremely low gestational age newborns. Indian Pediatr 2015; 52 (03) 227-230
• 6 Iyer NP, Mhanna MJ. The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants. World J Pediatr 2014; 10 (03) 204-210
• 7 Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009; (02) CD007836
• 8 Engle WA. ; American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121 (02) 419-432
• 9 Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. ; COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358 (07) 700-708
• 10 Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012; (03) CD000510
• 11 Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics 2014; 133 (01) 171-174
• 12 Kong X, Cui Q, Hu Y. , et al. Bovine surfactant replacement therapy in neonates of less than 32 weeks' gestation: a multicenter controlled trial of prophylaxis versus early treatment in China--a pilot study. Pediatr Neonatol 2016; 57 (01) 19-26
• 13 Liu J, Yang N, Liu Y. High-risk factors of respiratory distress syndrome in term neonates: a retrospective case-control study. Balkan Med J 2014; 31 (01) 64-68
• 14 Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015; 169 (08) 731-739
• 15 Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; (04) CD003063
• 16 Sandri F, Plavka R, Ancora G. , et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125 (06) e1402-e1409
• 17 Dunn MS, Kaempf J, de Klerk A. , et al; Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011; 128 (05) e1069-e1076
• 18 Kandraju H, Murki S, Subramanian S, Gaddam P, Deorari A, Kumar P. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial. Neonatology 2013; 103 (02) 148-154